Lv41
650 积分 2024-03-12 加入
Repeated switching between biosimilar ABP 654 and reference ustekinumab in patients with moderate-to-severe plaque psoriasis: a randomized, double-blinded clinical trial to support interchangeability
15天前
已完结
Pregnancy Outcomes in Biologic-Exposed Psoriasis Patients: A Large Cohort Study of Real-World Safety
15天前
已完结
AI-Powered Imaging for Objective Psoriasis Severity Assessment at Home: Feasibility and Reliability in a Randomized Clinical Trial
15天前
已完结
Drug survival of bimekizumab, guselkumab, and risankizumab after secondary IL‐17 inhibitor failure
15天前
已完结
Clinical utility of immune biomarker staining of skin biopsies in psoriasis and eczematous dermatitis: A single-center retrospective analysis
15天前
已完结
The Lancet Commission on Skin Health: aligning with WHO priorities
20天前
已完结
International modified Delphi consensus statement on visible light photoprotection: Effects, measurement, and recommendations
1个月前
已关闭
Segmental vitiligo: A distinct entity with unique pathogenesis and clinical implications
1个月前
已完结
Vitiligo Metrics Lack Multidimensional Severity Domains
1个月前
已完结
Impact of Treatment Duration on Response Durability: A Post Hoc Analysis of the Double-Blind, Vehicle-Controlled, Randomized TRuE-V Long-Term Extension Study of Ruxolitinib Cream in Vitiligo
1个月前
已完结
皖公网安备34019202002308
